Diagnosing cancer more deftly will pay dividends

Given that 50% of Britons will develop the disease during their lifetimes, we need to get better at detecting it, says Matthew Partridge. These firms are leading the technological charge

Related Keywords

United Kingdom ,Germany ,German ,Julie Utterback ,Maximilian Martin ,Sara Torrecilla ,Lombard Odier ,Ovid Amadi ,Elena Viboch ,Luke Barrs ,Siemens Healthineers ,Sciences Nasdaq ,Siemens ,Drug Administration ,Macmillan Cancer ,Goldman Sach Asset ,General Catalyst ,Exact Sciences ,